DK144093D0 - - Google Patents
Info
- Publication number
- DK144093D0 DK144093D0 DK144093A DK144093A DK144093D0 DK 144093 D0 DK144093 D0 DK 144093D0 DK 144093 A DK144093 A DK 144093A DK 144093 A DK144093 A DK 144093A DK 144093 D0 DK144093 D0 DK 144093D0
- Authority
- DK
- Denmark
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK144093A DK144093D0 (enrdf_load_html_response) | 1993-12-23 | 1993-12-23 | |
PCT/DK1994/000487 WO1995017510A1 (en) | 1993-12-23 | 1994-12-22 | A method of producing glucagon-like peptide 1 |
AU12725/95A AU1272595A (en) | 1993-12-23 | 1994-12-22 | A method of producing glucagon-like peptide 1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK144093A DK144093D0 (enrdf_load_html_response) | 1993-12-23 | 1993-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK144093D0 true DK144093D0 (enrdf_load_html_response) | 1993-12-23 |
Family
ID=8104857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK144093A DK144093D0 (enrdf_load_html_response) | 1993-12-23 | 1993-12-23 |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1272595A (enrdf_load_html_response) |
DK (1) | DK144093D0 (enrdf_load_html_response) |
WO (1) | WO1995017510A1 (enrdf_load_html_response) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
PT944648E (pt) * | 1996-08-30 | 2007-06-26 | Novo Nordisk As | Derivados do glp-1. |
US6461834B1 (en) | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
CA2405550A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CN1162446C (zh) * | 2001-05-10 | 2004-08-18 | 上海华谊生物技术有限公司 | 促胰岛素分泌肽衍生物 |
CN1363654A (zh) * | 2001-07-19 | 2002-08-14 | 上海华谊生物技术有限公司 | 生产促胰岛素分泌肽glp-1(7-36)的基因工程菌以及生产glp-1(7-36)的方法 |
EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
WO2003099854A2 (en) | 2002-05-24 | 2003-12-04 | Nps Allelix Corp. | Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
CA2485701A1 (en) * | 2002-05-24 | 2003-12-04 | Fred W. Wagner | Method for enzymatic production of glp-1 (7-36) amide peptides |
WO2003099848A2 (en) | 2002-05-24 | 2003-12-04 | Restoragen Inc. | Method for universal enzymatic production of bioactive peptides |
CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7829307B2 (en) | 2003-11-21 | 2010-11-09 | Nps Pharmaceuticals, Inc. | Production of glucagon-like peptide 2 |
HUE027902T2 (en) * | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
CN100429227C (zh) | 2005-06-29 | 2008-10-29 | 常州制药厂有限公司 | Exendin4多肽片段 |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
US11291693B2 (en) | 2015-06-25 | 2022-04-05 | Synlogic Operating Company, Inc. | Bacteria engineered to treat metabolic diseases |
WO2017139708A1 (en) | 2016-02-10 | 2017-08-17 | Synlogic, Inc. | Bacteria engineered to treat nonalcoholic steatohepatitis (nash) |
EP3601328A1 (en) | 2017-03-20 | 2020-02-05 | Lupin Limited | Expression and large-scale production of peptides |
CN113846124A (zh) * | 2021-09-26 | 2021-12-28 | 康霖生物科技(杭州)有限公司 | 一种用于糖代谢相关疾病基因治疗的核酸构建体 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK27885A (da) * | 1985-01-22 | 1986-07-23 | Novo Industri As | Fremstilling af peptider |
US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
US5118666A (en) * | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
CA1320162C (en) * | 1988-08-11 | 1993-07-13 | California Biotechnology Inc. | Method for stabilizing heterologous protein expression and vectors for use therein |
DK0512042T3 (da) * | 1990-01-24 | 1998-05-11 | Douglas I Buckley | GLP-1-analoger anvendelige ved diabetesbehandling |
US5202239A (en) * | 1990-08-07 | 1993-04-13 | Scios Nova Inc. | Expression of recombinant polypeptides with improved purification |
-
1993
- 1993-12-23 DK DK144093A patent/DK144093D0/da not_active Application Discontinuation
-
1994
- 1994-12-22 AU AU12725/95A patent/AU1272595A/en not_active Abandoned
- 1994-12-22 WO PCT/DK1994/000487 patent/WO1995017510A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995017510A1 (en) | 1995-06-29 |
AU1272595A (en) | 1995-07-10 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A0 | Application filed | ||
ATS | Application withdrawn |